Back to search

France· FR:69702041

ENOXAPARINE ZENTIVA 4 000 UI (40 mg)/0,4 mL, solution injectable en seringue préremplie

A enoxaparin product containing énoxaparine sodique, registered in France by ZENTIVA FRANCE, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC B01AB05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedENOXAPARINE ZENTIVA 4 000 UI (40 mg)/…ATCB01AB05REGISTER NO.FR:69702041PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Enoxaparin is registered in 16 of 19 countries.

Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Enoxaparin · ATC B01AB05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉNOXAPARINE SODIQUE
Manufacturer
ZENTIVA FRANCE
Country
France (FR)
ATC code
B01AB05
ATC class
Enoxaparin
Defined daily dose
2 TSD, E
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930317914
    2 seringues préremplies en verre de 0,4 mL
    EUR 8.53
  • cip13
    3400930317921
    6 seringues préremplies en verre de 0,4 mL
    EUR 25.45

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for enoxaparin.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Enoxaparin · interactions on record

203 records

  • 106 severe
  • 73 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f62b36b6-2ce5-4fe0-b16c-99726a9c27d1
GET /v1/drugs/f62b36b6-2ce5-4fe0-b16c-99726a9c27d1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69702041",
  "date_amm": "2025-05-27",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ÉNOXAPARINE SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse;sous-cutanée;voie extracorporelle autre",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about enoxaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.